These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34195190)

  • 1. WIP, YAP/TAZ and Actin Connections Orchestrate Development and Transformation in the Central Nervous System.
    Antón IM; Wandosell F
    Front Cell Dev Biol; 2021; 9():673986. PubMed ID: 34195190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma.
    Rivas S; Antón IM; Wandosell F
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29890731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles and mechanisms of the Hippo/YAP signaling pathway in the nervous system.
    Bao XM; He Q; Wang Y; Huang ZH; Yuan ZQ
    Yi Chuan; 2017 Jul; 39(7):630-641. PubMed ID: 28757477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.
    Gargini R; Escoll M; García E; García-Escudero R; Wandosell F; Antón IM
    Cell Rep; 2016 Nov; 17(8):1962-1977. PubMed ID: 27851961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
    Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 15. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of Yap and Taz during development of the mandibular first molar in rats.
    Zhang B; Sun BY; Ji YW; Zhang YP; Wang XX; Xu X; Wen Y
    Biotech Histochem; 2017; 92(3):212-221. PubMed ID: 28402144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo-YAP/TAZ signaling in angiogenesis.
    Park JA; Kwon YG
    BMB Rep; 2018 Mar; 51(3):157-162. PubMed ID: 29366443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.